Chemical firms see opportunity in biocatalysis

08/13/2013 | Motley Fool, The

BASF, Novozymes and DuPont are among the companies that see opportunities in biocatalysts, which speed chemical reactions and aid pharmaceutical manufacturing. The market for these enzymes could reach $5 billion per year, according to this article. BASF now has pharmaceutical enzyme manufacturing lines in the U.S., India and Italy.

View Full Article in:

Motley Fool, The

Published in Brief: